--- title: "JIANGNAN RED ARROW: Net profit loss of 40.7148 million yuan in the first half of 2025, a decrease of 191.32%" type: "News" locale: "en" url: "https://longbridge.com/en/news/253963271.md" description: "JIANGNAN RED ARROW announced that in the first half of 2025, operating revenue was 2.193 billion yuan, a year-on-year increase of 17.36%. The net profit loss was 40.7148 million yuan, a decrease of 191.32%. The company plans not to distribute cash dividends, not to issue bonus shares, and not to convert reserves into share capital" datetime: "2025-08-21T10:22:41.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/253963271.md) - [en](https://longbridge.com/en/news/253963271.md) - [zh-HK](https://longbridge.com/zh-HK/news/253963271.md) generator: "portal-rs" --- # JIANGNAN RED ARROW: Net profit loss of 40.7148 million yuan in the first half of 2025, a decrease of 191.32% JIANGNAN RED ARROW announced that in the first half of 2025, operating revenue was 2.193 billion yuan, a year-on-year increase of 17.36%. The net profit loss was 40.7148 million yuan, a decrease of 191.32%. The company plans not to distribute cash dividends, not to issue bonus shares, and not to convert reserves into share capital ### Related Stocks - [000519.CN](https://longbridge.com/en/quote/000519.CN.md) ## Related News & Research - [Multicoin Capital-Linked Wallet Transfers 197,560 HYPE to CEX, Raising Sale Concerns](https://longbridge.com/en/news/296661501.md) - [WTM: Aggressive drilling and strategic acquisitions drove a $20.1M loss but strengthened district control](https://longbridge.com/en/news/296543618.md) - [CSG-owned Federal Ammunition wins Nordic Police contract for up to 35 million rifle rounds](https://longbridge.com/en/news/296496114.md) - [13:49 ETVascarta Outlines Proposed Mechanistic Link Between VAS-101's (Vasceptor®) Vascular and Red Blood Cell Effects in Sickle Cell Disease](https://longbridge.com/en/news/296524035.md) - [Drillcon extends Boliden Zinkgruvan exploration drilling contract to 2029](https://longbridge.com/en/news/296604619.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**